Delivery Order SPE2DB20D6037-SPE2DB25FTWH5
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract award, valued at $22,871.96, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 29, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $55,064.59 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products to fulfill the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $67,360.25, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program for the supply of a wide range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $29,520.62, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, valued at up to $499,999,999, which runs through...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,610.08 and covers the delivery of HUMIRA PEN 40 MG/0.8 MLS, a specialized pharmaceutical product, with a performance period ending on March 29, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $15,751.69 firm fixed-price delivery order is for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The delivery order was issued against an indefinite delivery vehicle (IDV) contract, SPE2DB24D2106|SPE2DB24FAUAA, with a ceiling value of up to $4,999,999 through 2025. This IDV contract enables DLA to place orders for a broad range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $35,289.60 firm fixed-price contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription pharmaceutical product, with a ceiling value of $39,794.36 and a period of performance through June 11, 2024. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,856.31 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $19,959.59, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription pharmaceutical product. The award is part of a larger indefinite delivery contract, SPE2DB24D2106, valued at up to $4,999,999 through the end of 2025. This single-award contract enables DLA to issue firm fixed-price delivery orders for a broad range of...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB25FTWH5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,510.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract calls for the delivery of Humira 40 mg/0.8 ml syringes to support federal healthcare needs. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, and performance will take place in Conshohocken, Pennsylvania. This award represents a typical transactional delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 and extends through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the DLA to fulfill individual delivery orders for specific medications required by military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/11/25 |